KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Other Accumulated Expenses (2016 - 2025)

Humana (HUM) has disclosed Other Accumulated Expenses for 16 consecutive years, with $10.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $10.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.0 billion, a N/A change, with the full-year FY2025 number at $10.0 billion, changed N/A from a year prior.
  • Other Accumulated Expenses was $10.0 billion for Q4 2025 at Humana, down from $10.1 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $11.5 billion in Q1 2025 to a low of $8.3 billion in Q4 2021.
  • A 4-year average of $9.7 billion and a median of $9.6 billion in 2022 define the central range for Other Accumulated Expenses.
  • Biggest YoY gain for Other Accumulated Expenses was 22.02% in 2021; the steepest drop was 1.79% in 2021.
  • Humana's Other Accumulated Expenses stood at $8.3 billion in 2021, then increased by 11.76% to $9.3 billion in 2022, then increased by 10.06% to $10.2 billion in 2023, then dropped by 2.25% to $10.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Other Accumulated Expenses are $10.0 billion (Q4 2025), $10.1 billion (Q3 2025), and $11.1 billion (Q2 2025).